This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Banks At Risk of a Commercial Real Estate Double Dip

2. BancorpSouth

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Shares of Bancorp South (BXS - Get Report) are down 24% year to date.

Shares of BancorpSouth (BXS - Get Report) are down 24% year-tp-date.

The bank, which like Synovus is also operates in the SouthEast, has faced deteriorating credit quality with total nonperforming loans increasing to 4.61% of net loans and leases in the first quarter from 2.43% in the year ago quarter.

BancorpSouth had commercial real estate loans worth $4.05 billion or 321% of its capital at the end of the first quarter. Nonperforming CRE (construction and commercial mortgages) loans at the end of the first quarter totaled accounted for 22% of capital.

"With 12% of total loans being C&D and 19% of these loans currently nonperforming, the bank currently has $886 million of performing C&D loans, very high, in our view, given only $921 million in TCE(Tangible common equity) at YE10," JPMorgan analysts said in a note last month.

"We also note that 74% of BXS's C&D loans are scheduled to mature in 2011, which we believe adds substantially to the bank's riskprofile. Although many banks are now in the process of restoring dividends, given the size of a stressed C&D portfolio at BXS relative to total capital and seeming near-term earnings power (which we peg in the range of $0.01 to $0.07 per share over the next several quarters), we believe this was the driver of the Board's recent decision to cut the dividend yet again."

On April 29, the company announced it would cut its quarterly dividend from 11 cents to a penny, which the management said was done to better preserve BancorpSouth's strong capital position.

There are no buy ratings on the stock. 13 analysts have a hold rating, while only one analyst has a sell call on the stock.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BPOP $29.76 -1.00%
BXS $25.59 -2.00%
FBP $4.80 -1.90%
SNV $30.58 -1.50%
AAPL $126.23 -0.29%

Markets

DOW 17,718.96 -38.95 -0.22%
S&P 500 2,073.06 -4.36 -0.21%
NASDAQ 4,999.0930 -14.03 -0.28%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs